bromocriptine has been researched along with Angiogenesis, Pathologic in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Kasica, N; Mackiewicz, J; Osęka, M; Saładziak, K; Święch, A | 1 |
Cai, L; Guo, YH; Jin, K; Leng, ZG; Lin, SJ; Lu, JL; Su, ZP; Wei, LF; Wu, ZB; Wu, ZR; Zhuge, QC | 1 |
Cenci, MA; Lindgren, HS; Ohlin, KE | 1 |
Arany, Z; Bauersachs, J; Burke, SD; del Monte, F; Farrell, C; Hacker, MR; Hess, P; Hilfiker-Kleiner, D; Jang, C; Karumanchi, SA; Khankin, EV; Koulisis, N; Liu, L; Mahmood, F; Mitchell, J; Patten, IS; Rana, S; Rhee, JS; Rowe, GC; Shahul, S; Tudorache, I | 1 |
Horvath, E; Kovacs, K; Kuroki, T; Lloyd, RV; Scheithauer, BW; Vidal, S | 2 |
Ansari, A; Balligand, JL; Bonda, T; Desjardins, F; Doerries, C; Drexler, H; Forster, O; Heusch, G; Hilfiker, A; Hilfiker-Kleiner, D; Kaminski, K; Klein, G; Landmesser, U; Luchtefeld, M; Nguyen, NQ; Podewski, E; Poli, V; Quint, A; Schaefer, A; Schneider, MD; Schulz, R; Sliwa, K; Struman, I; Zschemisch, NH | 1 |
Takechi, A | 1 |
1 trial(s) available for bromocriptine and Angiogenesis, Pathologic
Article | Year |
---|---|
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.
Topics: Animals; Bromocriptine; Cardiomyopathies; Cathepsin D; Disease Models, Animal; Female; Heart Transplantation; Humans; Hypertrophy, Left Ventricular; Lactation; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Neovascularization, Pathologic; Oxidative Stress; Peptide Fragments; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; STAT3 Transcription Factor | 2007 |
7 other study(ies) available for bromocriptine and Angiogenesis, Pathologic
Article | Year |
---|---|
The Inhibitory Effect of Selected D
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Bromocriptine; Cabergoline; Dopamine Agonists; Hypoxia; Larva; Neovascularization, Pathologic; Pergolide; Vascular Endothelial Growth Factor A; Zebrafish | 2022 |
Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas.
Topics: Adolescent; Adult; Aged; Animals; Bromocriptine; Case-Control Studies; Cell Proliferation; Cell Survival; Cells, Cultured; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Gene Knockdown Techniques; Human Umbilical Vein Endothelial Cells; Humans; Male; Middle Aged; Neoplasm Proteins; Neovascularization, Pathologic; Pituitary Neoplasms; Prolactinoma; Proteoglycans; Rats; Young Adult | 2016 |
Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Antiparkinson Agents; Basal Ganglia; Benzazepines; Bromocriptine; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Extracellular Signal-Regulated MAP Kinases; Female; Levodopa; Neovascularization, Pathologic; Oxidopamine; Parkinsonian Disorders; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 2009 |
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.
Topics: Animals; Bromocriptine; Cardiomyopathies; Disease Models, Animal; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Neovascularization, Pathologic; Neovascularization, Physiologic; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Trans-Activators; Transcription Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2012 |
Expression of hypoxia-inducible factor-1alpha (HIF-1alpha) in pituitary tumours.
Topics: Adenoma; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Bromocriptine; Carcinoma; Cell Division; Cell Nucleolus; Cell Nucleus; Child; Cytoplasm; Dopamine Agonists; Endothelium, Vascular; Female; Hormone Antagonists; Hormones; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Male; Microcirculation; Middle Aged; Neovascularization, Pathologic; Octreotide; Pituitary Neoplasms; Somatostatin; Transcription Factors | 2003 |
Effect of angiogenesis inhibitor TNP-470 on vascular formation in pituitary tumors induced by estrogen in rats.
Topics: Animals; Bromocriptine; Cyclohexanes; Estradiol; Female; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Pituitary Neoplasms; Rats; Rats, Inbred F344; Sesquiterpenes | 1994 |
Microvessel density in pituitary adenomas and carcinomas.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD34; Antigens, Nuclear; Bromocriptine; Carcinoma; Child; Dopamine Agonists; Female; Hormones; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Microcirculation; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Nuclear Proteins; Octreotide; Pituitary Neoplasms | 2001 |